Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science. He is the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer. As the co-chair of Bioinformatics and Biotechnology at the Singularity University, he addresses the disruptive shifts underway in life. He speaks widely on topics that include cells as living computers, life science as an emerging IT industry, and biological safety and security. He is active in the iGEM and DIYbio (do-it-yourself) communities and frequently works with students and young entrepreneurs.